1. AB0167 ACR/EULAR Remission in Early Rheumatoid Arthritis Associates with A Shorter Time To Fulfilment The Classification Criteria and A Lower Bmi. (15th July 2016) Authors: Zabotti, A.; Quartuccio, L.; Salvin, S.; Picco, L.; Sacco, S.; De Vita, S. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 953 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. FRI0255 The 158vv fcgamma receptor 3a genotype is associated with response to rituximab in rheumatoid arthritis: results of an italian multicentre study. (23rd January 2014) Authors: Quartuccio, L.; Fabris, M.; Pontarini, E.; Salvin, S.; Zabotti, A.; Benucci, M.; Manfredi, M.; Biasi, D.; Ravagnani, V.; Atzeni, F.; Sarzi Puttini, P.; Morassi, P.; Fischetti, F.; Tomietto, P.; Bazzichi, L.; Saracco, M.; Pellerito, R.; Cimmino, M.; Schiavon, F.; Carraro, V. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A460 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. FRI0282 Serological biomarkers of b-cell lymphoproliferative disorders in patients with primary sjögren's syndrome: retrospective study in a large italian cohort. (23rd January 2014) Authors: Quartuccio, L.; Isola, M.; Baldini, C.; Priori, R.; Bartoloni, E.; Carubbi, F.; Maset, M.; Della Mea, V.; Salvin, S.; Luciano, N.; Minniti, A.; Alunno, A.; Gregoraci, G.; Giacomelli, R.; Gerli, R.; Valesini, G.; Bombardieri, S.; De Vita, S. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A469 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. SAT0205 Blys up-regulation and salivary clonal B-cell expansion characterize sjögren's syndrome-related lymphoproliferative disorders and correlate with the new ESSDAI score. (23rd January 2014) Authors: Quartuccio, L.; Salvin, S.; Fabris, M.; Maset, M.; Corazza, L.; Pontarini, E.; Isola, M.; De Vita, S. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 541 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. SAT0233 Characteristics of primary sjögren's syndrome (PSS) patients with cryoglobulinemia in a large cohort of patients, and differences between hypergammaglobulinemic and cryoglobulinemic vasculitis in PSS. (23rd January 2014) Authors: Quartuccio, L.; Maset, M.; Baldini, C.; Priori, R.; Bartoloni Bocci, E.; Carubbi, F.; Isola, M.; Salvin, S.; Luciano, N.; Minniti, A.; Alunno, A.; Gregoraci, G.; Giacomelli, R.; Gerli, R.; Valesini, G.; Bombardieri, S.; De Vita, S. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 550 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. THU0188 Lymphoproliferative complications in the course of primary sjægren's syndrome: Prevalence and common features in a large cohort of patients. (23rd January 2014) Authors: Quartuccio, L.; Baldini, C.; Priori, R.; Bartoloni Bocci, E.; Carubbi, F.; Isola, M.; Maset, M.; Salvin, S.; Luciano, N.; Picarelli, G.; Alunno, A.; Marrelli, A.; Gerli, R.; Valesini, G.; Bombardieri, S.; De Vita, S. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 219 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. THU0392 Efficacy and Safety of Belimumab Given for 12 Months in Primary sjögren's Syndrome: The Beliss Open-Label Phase II Study. (9th June 2015) Authors: De Vita, S.; Quartuccio, L.; Seror, R.; Salvin, S.; Ravaud, P.; Fabris, M.; Nocturne, G.; Gandolfo, S.; Isola, M.; Mariette, X. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 338 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. THU0394 Worsening of Systemic Activity and Increases of B-Cell Biomarkers in sjögren's Syndrome after Suspension of Belimumab Treatment: Long-Term Follow-Up After the End of the Beliss Study. (9th June 2015) Authors: Quartuccio, L.; Salvin, S.; Corazza, L.; Gandolfo, S.; Pistis, C.; Fabris, M.; De Vita, S. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 339 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗